AI assistant
Sending…
Bone Biologics Corp — Director's Dealing 2024
Oct 18, 2024
35440_dirs_2024-10-18_c8505652-5791-4678-a997-4d095d60389c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2024-10-16
Reporting Person: Meikle Phillip Terry II (Director)
More from Bone Biologics Corp
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Mar 2
Director's Dealing
2026
Jan 21
Director's Dealing
2026
Jan 21
Regulatory Filings
2026
Jan 8
Interim / Quarterly Report
2025
Nov 14
Major Shareholding Notification
2025
Nov 7
Regulatory Filings
2025
Sep 26
Regulatory Filings
2025
Sep 4
Regulatory Filings
2025
Aug 29